Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.
Clinical trial NCT07079761 · RECRUITING
Trial details
- NCT number
- NCT07079761
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-04
- Primary completion
- 2027-04-30
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.